Revolution Medicines, Inc. Warr
RVMDW
Last
$9.77
Day
+3.9%
1y
+2598.7%
5y
+844.1%
52w
-29.8%
SPY YTD
+13.3%
Sec
—
Earnings
—
EMA 21
10.79
EMA 50
10.59
EMA 200
7.02
20d high
-21.3%
5y high
-29.8%
5y range
70th
Positions held
Your positionsRVMDW isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
9
Hold
watch
Signal
Neutral
Target
$12.32
Stop
$8.00
Stop distance
18.1%
Target vs last
+26.2%
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | 0.78 | Beta | 1.40 | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -79.1% | ROA | -30.1% | Debt / equity | 0.46 |
| Current ratio | 11.38 | Free cash flow | -$711.61M | Analyst recommendation | none | Mean target | — |
| 52w high | $10.65 | 52w low | $8.75 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$644M | -$454M | -$365M | -$305M | -$248M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$505M | -$445M | -$362M | -$315M | -$265M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $11.6M | $35.4M |
| Op margin | — | — | -4207.1% | -730.0% |
| Net income | -$1.1B | -$600M | -$436M | -$249M |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | -$1.2B | -$690M | -$487M | -$258M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
No headlines.
Price (daily)
Full chart · RSI · MACD · patternsRVMDW · daily-5.9% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin